127 related articles for article (PubMed ID: 26142745)
1. Application of HPLC to assess the compatibility of bisoprolol fumarate with selected excipients in mixtures by isothermal stress testing.
Marothu VK; Yerramothu P; Gorrepati M; Majeti S; Mamidala SK; Nellutla A
Ann Pharm Fr; 2015 Nov; 73(6):442-51. PubMed ID: 26142745
[TBL] [Abstract][Full Text] [Related]
2. The Maillard reaction of bisoprolol fumarate with various reducing carbohydrates.
Szalka M; Lubczak J; Naróg D; Laskowski M; Kaczmarski K
Eur J Pharm Sci; 2014 Aug; 59():1-11. PubMed ID: 24746680
[TBL] [Abstract][Full Text] [Related]
3. Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
Prachi S; Komal C; Priti MJ
AAPS PharmSciTech; 2017 Oct; 18(7):2410-2417. PubMed ID: 28155135
[TBL] [Abstract][Full Text] [Related]
4. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation.
Kumar V; Shah RP; Malik S; Singh S
J Pharm Biomed Anal; 2009 May; 49(4):880-8. PubMed ID: 19217740
[TBL] [Abstract][Full Text] [Related]
5. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
6. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
Verma RK; Garg S
J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
[TBL] [Abstract][Full Text] [Related]
7. Compatibility of sennoside A and B with pharmaceutical excipients.
Verloop Q; Marais AF; de Villiers MM; Liebenberg W
Pharmazie; 2004 Sep; 59(9):728-30. PubMed ID: 15497761
[TBL] [Abstract][Full Text] [Related]
8. Drug-excipient compatibility studies in binary mixtures of avobenzone.
Ceresole R; Han YK; Rosasco MA; Orelli LR; Segall A
J Cosmet Sci; 2013; 64(5):317-28. PubMed ID: 24139431
[TBL] [Abstract][Full Text] [Related]
9. Preparation of bisoprolol fumarate nasal spray and its nasal delivery in rats.
Fugen G; Duo H; Gendalai M; Chunzhi W; Yi W
Pak J Pharm Sci; 2015 Nov; 28(6):2173-8. PubMed ID: 26639509
[TBL] [Abstract][Full Text] [Related]
10. Biowaiver monograph for immediate-release solid oral dosage forms: bisoprolol fumarate.
Charoo NA; Shamsher AA; Lian LY; Abrahamsson B; Cristofoletti R; Groot DW; Kopp S; Langguth P; Polli J; Shah VP; Dressman J
J Pharm Sci; 2014 Feb; 103(2):378-91. PubMed ID: 24382794
[TBL] [Abstract][Full Text] [Related]
11. Update on compatibility assessment of empagliflozin with the selected pharmaceutical excipients employed in solid dosage forms by thermal, spectroscopic and chromatographic techniques.
Niguram P; Polaka SN; Rathod R; Kalia K; Kate AS
Drug Dev Ind Pharm; 2020 Feb; 46(2):209-218. PubMed ID: 31933394
[TBL] [Abstract][Full Text] [Related]
12. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
[TBL] [Abstract][Full Text] [Related]
13. Design and utilization of the drug-excipient chemical compatibility automated system.
Thomas VH; Naath M
Int J Pharm; 2008 Jul; 359(1-2):150-7. PubMed ID: 18486368
[TBL] [Abstract][Full Text] [Related]
14. Validation of a spectrophotometric assay method for bisoprolol using picric acid.
Panainte AD; Bibire N; Tântaru G; Apostu M; Vieriu M
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):520-4. PubMed ID: 24340540
[TBL] [Abstract][Full Text] [Related]
15. Solid state compatibility studies with tablet excipients using non thermal methods.
Liltorp K; Larsen TG; Willumsen B; Holm R
J Pharm Biomed Anal; 2011 Jun; 55(3):424-8. PubMed ID: 21411259
[TBL] [Abstract][Full Text] [Related]
16. Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry.
Skotnicki M; Aguilar JA; Pyda M; Hodgkinson P
Pharm Res; 2015 Feb; 32(2):414-29. PubMed ID: 25115829
[TBL] [Abstract][Full Text] [Related]
17. Drug-excipient compatibility testing using a high-throughput approach and statistical design.
Wyttenbach N; Birringer C; Alsenz J; Kuentz M
Pharm Dev Technol; 2005; 10(4):499-505. PubMed ID: 16370179
[TBL] [Abstract][Full Text] [Related]
18. Compatibility studies of nateglinide with excipients in immediate release tablets.
Pani NR; Nath LK; Acharya S
Acta Pharm; 2011 Jun; 61(2):237-47. PubMed ID: 21684850
[TBL] [Abstract][Full Text] [Related]
19. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
20. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
